Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10814010
FOXC2 inhibitor and methods of use thereof
granted -
US 10814013
Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
granted -
US 10808230
Selection methods for genetically-modified T cells
granted -
US 10799466
Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
granted -
US 10800774
Heterocyclic inhibitors of ATR kinase
granted -
US 10800769
Heterocyclic inhibitors of ATR kinase
granted -
US 10772913
Administration of kynurenine depleting enzymes for tumor therapy
granted -
US 10765745
Multifunctional nanoparticle systems and methods for cancer diagnosis and combination therapy
granted -
US 10767179
MicroRNA composition for the treatment of neuroblastoma
granted -
US 10766892
GLS1 inhibitors for treating disease
granted -
US 10759833
VMP-like sequences of pathogenic Borrelia species and strains
granted -
US 10751409
Immunogenic compositions and uses thereof
granted -
US 10751348
Formulations of testosterone and methods of treatment therewith
granted -
US 10751416
IL-26 inhibitors
granted -
US 10745420
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
granted -
US 10744232
Antimicrobial catheters
granted -
US 10745474
Methods of treating inflammation associated airway diseases and viral infections
granted -
US 10738043
GLS1 inhibitors for treating disease
granted -
US 10736880
Therapeutics for preterm labor management
granted -
US 10729781
LGR4 specific monoclonal antibodies and methods of their use
granted -
US 10729693
Compositions and methods for the treatment of endometriosis
granted -
US 10724026
Engineered primate L-methioninase for therapeutic purposes
granted -
US 10722487
Glutaminase inhibitor therapy
granted -
US 10722573
Compositions for stimulation of mammalian innate immune resistance to pathogens
granted